February 11, 2021

BioLamina and Cellaria will collaborate to make accurate cell models for drug screening

One of the biggest challenges in drug development is the low success rate in development of drug candidates. This can be improved by development of tissue specific cellular models, with improved biological relevance in early drug development. A tissue is composed of both cells and extracellular proteins like the laminins and the intention of this partnership is to use the extracellular proteins and BioSilk from BioLamina to mimic the cell microenvironment and Cellarias iPSC reprogramming and disease model cells to make biologically relevant and accurate cell models for drug screening. These models could significantly decrease the cost of drug development.